RevvityRVTY财报
NYSE · 医疗保健 · 医疗保健设备
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14.40% | 17.8M | ▲ +1.70pp | 2024-11-14 |
| The Vanguard Group | 11.49% | 14.2M | — | 2024-02-13 |
| BlackRock, Inc. | 7.00% | 8.7M | — | 2024-01-26 |
| T. ROWE PRICE ASSOCIATES, INC. | 5.30% | 6.5M | — | 2024-11-14 |
| S.S. OR | 5.10% | 6.3M | — | 2024-11-14 |
| Select Equity Group, L.P. | 4.30% | 5.2M | ▼ -4.80pp | 2024-11-14 |
| OF ABOVE PERSONS | 2.50% | 3.1M | ▼ -3.70pp | 2024-11-12 |
内部人交易
Net 90d: −$4.68M · buys $0 / sells $4.68M时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-04-20 | Anita Gonzales | Vice President and CAO | Sell (open market) | 80 | $92.80 | $7.4K |
| 2026-03-16 | Anita Gonzales | Please See Remarks | Grant | 1.6K | $0.00 | $0 |
| 2026-03-06 | Anita Gonzales | Please See Remarks | Grant | 1.7K | $0.00 | $0 |
| 2026-02-24 | Miriame Victor | Please See Remarks | Option exercise | 1.9K | $95.74 | $178.3K |
| 2026-02-24 | Miriame Victor | Please See Remarks | Sell (open market) | 1.9K | $97.13 | $180.9K |
| 2026-02-23 | McMurry-Heath Michelle | Director | Sell (open market) | 600 | $97.26 | $58.4K |
| 2026-02-05 | Singh Prahlad R. | Please See Remarks | Option exercise | 25.5K | $92.09 | $2.35M |
| 2026-02-05 | Singh Prahlad R. | Please See Remarks | Sell (open market) | 1.3K | $99.02 | $129.4K |
| 2026-02-05 | Singh Prahlad R. | Please See Remarks | Sell (open market) | 12.2K | $99.55 | $1.21M |
| 2026-02-05 | Singh Prahlad R. | Please See Remarks | Sell (open market) | 7.9K | $100.63 | $793.5K |
1–10 of 24
第 1 页 / 共 3 页